Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Nov 17;323(7322):1164-7.
doi: 10.1136/bmj.323.7322.1164.

Treatment of chronic hepatitis

P J Gow  1 , D Mutimer
Affiliations
Review

Treatment of chronic hepatitis

P J Gow et al. BMJ. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Natural course of primary hepatitis B infection acquired during childhood or adulthood
Figure 2
Figure 2
Outcome of prolonged treatment with lamivudine in patients with hepatitis B
Figure 3
Figure 3
Natural course of hepatitis C infection
Figure 4
Figure 4
Liver with cirrhosis due to hepatitis C and large hepatoma
See this image and copyright information in PMC

References

    1. Gay NJ, Hesketh LM, Osborne KP, Farrington CP, Morgan-Capner P, Miller E. The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol Infect. 1999;122:133–138. - PMC - PubMed
    1. Cunningham R, Northwood JL, Kelly CD, Boxall EH, Andrews NJ. Routine antenatal screening for hepatitis B using pooled sera: validation and review of 10 years experience. J Clin Pathol. 1998;51:392–395. - PMC - PubMed
    1. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med. 1998;339:61–68. - PubMed
    1. Chien RN, Liaw YF, Atkins M. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group. Hepatology. 1999;30:770–774. - PubMed
    1. Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, et al. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. Hepatology. 1999;29:889–896. - PubMed

MeSH terms